Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 3 | 156.25 | 80.34 | 90.00 | 86.25 | 1.0435 | 2.0314 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 156.25 | 80.34 | 115.00 | 86.25 | 1.3333 | 32.2557 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 3 | 156.25 | 80.34 | 165.00 | 86.25 | 1.9130 | 1131.1351 |
| SK-BR-3 | PLX-4720 | 10 | uM | 3 | 156.25 | 80.34 | 111.00 | 86.25 | 1.2870 | 22.5305 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 3 | 156.25 | 80.34 | 122.00 | 86.25 | 1.4145 | 58.2409 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 3 | 156.25 | 80.34 | 1787.00 | 86.25 | 20.7188 | 14583671390700.0000 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 156.25 | 80.34 | 82.00 | 86.25 | 0.9507 | 0.2207 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 156.25 | 80.34 | 78.00 | 86.25 | 0.9044 | -0.2512 |
| SK-BR-3 | PLX-4720 | 1 | uM | 3 | 156.25 | 80.34 | 95.00 | 86.25 | 1.1014 | 4.1414 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 156.25 | 80.34 | 59.00 | 86.25 | 0.6841 | -0.9511 |
| SK-BR-3 | Nilotinib | 10 | uM | 3 | 156.25 | 80.34 | 616.00 | 86.25 | 7.1420 | 440686361.1920 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 156.25 | 80.34 | 115.00 | 86.25 | 1.3333 | 32.2557 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 156.25 | 80.34 | 68.00 | 86.25 | 0.7884 | -0.8041 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 63.00 | 86.25 | 0.7304 | -0.9071 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 63.00 | 86.25 | 0.7304 | -0.9071 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 103.00 | 86.25 | 1.1942 | 10.3291 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 80.00 | 86.25 | 0.9275 | -0.0410 | |
| SK-BR-3 | Etoposide | 1 | uM | 3 | 156.25 | 80.34 | 60.00 | 86.25 | 0.6957 | -0.9423 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 3 | 156.25 | 80.34 | 107.00 | 86.25 | 1.2406 | 15.4392 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 84.00 | 86.25 | 0.9739 | 0.5447 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 3 | 156.25 | 80.34 | 35.00 | 86.25 | 0.4058 | -0.9997 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 156.25 | 80.34 | 87.00 | 86.25 | 1.0087 | 1.1766 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 156.25 | 80.34 | 103.00 | 86.25 | 1.1942 | 10.3291 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 156.25 | 80.34 | 92.00 | 86.25 | 1.0667 | 2.7576 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 3 | 156.25 | 80.34 | 115.00 | 86.25 | 1.3333 | 32.2557 |